An Insider George Lemaitre Sold 45000 shares of LeMaitre Vascular, Inc. (LMAT); Synovus Financial Corp. (SNV) Covered By 8 Bullish Analysts Last Week

Among 19 analysts covering Synovus Financial Corp. (NYSE:SNV), 8 have Buy rating, 1 Sell and 10 Hold. Therefore 42% are positive. Synovus Financial Corp. had 57 analyst reports since July 22, 2015 according to SRatingsIntel. The company was maintained on Wednesday, January 24 by Stephens. The firm has “Hold” rating by Jefferies given on Wednesday, October 18. The rating was maintained by SunTrust on Tuesday, January 23 with “Buy”. Barclays Capital maintained it with “Hold” rating and $53.0 target in Tuesday, January 2 report. The firm earned “Underweight” rating on Friday, October 9 by Barclays Capital. The firm has “Hold” rating by Robert W. Baird given on Friday, September 29. Compass Point downgraded the stock to “Neutral” rating in Friday, November 18 report. The stock has “Hold” rating by Jefferies on Tuesday, October 10. As per Wednesday, October 18, the company rating was maintained by Barclays Capital. On Tuesday, October 17 the stock rating was maintained by RBC Capital Markets with “Buy”. See Synovus Financial Corp. (NYSE:SNV) latest ratings:

26/02/2018 Broker: Keefe Bruyette & Woods Rating: Hold New Target: $55.0 Maintain
26/01/2018 Broker: Morgan Stanley Old Rating: Underweight New Rating: Underperform Old Target: $50 New Target: $52 Maintain
24/01/2018 Broker: Stephens Rating: Buy New Target: $56.0 Maintain
23/01/2018 Broker: RBC Capital Markets Rating: Buy New Target: $55.0 Maintain
23/01/2018 Broker: Hovde Group Rating: Hold New Target: $53.0 Maintain
23/01/2018 Broker: Sandler O’Neill Rating: Buy New Target: $57.0 Maintain
23/01/2018 Broker: SunTrust Rating: Buy New Target: $62.0 Maintain
24/01/2018 Broker: Barclays Capital Old Rating: Equal-Weight New Rating: Equal-Weight Old Target: $53 New Target: $55 Maintain
24/01/2018 Broker: Bank of America Old Rating: Buy New Rating: Buy Old Target: $55 New Target: $56 Maintain
08/01/2018 Broker: SunTrust Rating: Buy New Target: $60.0 Maintain

After the publishing of a report filled with U.S. Security and Exchange Commission; a substantial insider trading transaction became apparent. The Chairman and CEO of Lemaitre Vascular Inc, George Lemaitre; made a considerable trade in the open market by selling 45,000 shares at the average stock price which was $34.7 of the Pinksheet-listed company having a total value of $1,559,711 U.S Dollars. George is trying to silently decrease his company’s share, same as he did in the last month. He sold another 60,590 shares worth $2,161,237 USD. This is a major sell, and one that is unlikely to remain unseen, as it decreased his ownership of Lemaitre Vascular Inc to 16.91% market capitalization, for a total of 3.26 million shares.

Among 12 analysts covering LeMaitre Vascular (NASDAQ:LMAT), 6 have Buy rating, 0 Sell and 6 Hold. Therefore 50% are positive. LeMaitre Vascular has $93 highest and $13 lowest target. $31.70’s average target is -10.40% below currents $35.38 stock price. LeMaitre Vascular had 37 analyst reports since July 29, 2015 according to SRatingsIntel. The rating was maintained by Canaccord Genuity on Tuesday, May 3 with “Buy”. Stifel Nicolaus maintained the shares of LMAT in report on Friday, December 4 with “Buy” rating. The stock has “Neutral” rating by Sidoti on Thursday, September 22. The rating was maintained by Roth Capital with “Buy” on Friday, July 28. The firm earned “Neutral” rating on Wednesday, January 20 by Sidoti. The company was downgraded on Friday, October 27 by First Analysis. The rating was downgraded by Benchmark to “Hold” on Friday, October 27. Barrington Research downgraded the stock to “Mkt Perform” rating in Wednesday, February 22 report. Stifel Nicolaus maintained the shares of LMAT in report on Friday, October 27 with “Buy” rating. Stifel Nicolaus maintained it with “Buy” rating and $40.0 target in Thursday, February 22 report.

LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. The company has market cap of $681.59 million. The firm provides angioscope, a fiber optic catheter used for viewing the lumen of a blood vessel; carotid shunts to temporarily divert or shut blood to the brain during the removal of plaque from the carotid artery in a carotid endarterectomy surgery; and powered phlebectomy devices that enable removal of varicose veins. It has a 41.14 P/E ratio. It also offers embolectomy catheters to remove blood clots from arteries or veins; occlusion catheters that temporarily occlude blood flow; and perfusion catheters that temporarily perfuse blood and other liquids into the vasculature.

Since February 26, 2018, it had 0 insider buys, and 1 sale for $2.16 million activity. On Monday, February 26 the insider LeMaitre George W sold $2.16 million.

The stock increased 0.65% or $0.23 during the last trading session, reaching $35.38. About 88,416 shares traded. LeMaitre Vascular, Inc. (NASDAQ:LMAT) has risen 101.07% since March 6, 2017 and is uptrending. It has outperformed by 84.37% the S&P500.

Investors sentiment is 1.71 in Q3 2017. Its the same as in 2017Q2. It is flat, as 11 investors sold LeMaitre Vascular, Inc. shares while 38 reduced holdings. only 27 funds opened positions while 57 raised stakes. 13.06 million shares or 7.12% more from 12.19 million shares in 2017Q2 were reported. Creative Planning invested in 0% or 5,346 shares. Ny State Common Retirement Fund holds 15,000 shares. Swiss Retail Bank holds 24,900 shares or 0% of its portfolio. 34 were reported by Tci Wealth Advsrs Inc. Guggenheim Ltd Liability Company holds 55,020 shares. Sanctuary Wealth Advsrs Ltd Co holds 0.01% in LeMaitre Vascular, Inc. (NASDAQ:LMAT) or 212 shares. Royal State Bank Of Canada holds 8,329 shares. Prudential Financial reported 141,757 shares or 0.01% of all its holdings. Envestnet Asset Mgmt Inc accumulated 3,376 shares. Bessemer Group holds 0% or 19,900 shares. Fiduciary Trust Co has 14,407 shares. Cubist Systematic Strategies Limited Liability Com has 0.01% invested in LeMaitre Vascular, Inc. (NASDAQ:LMAT). Federated Investors Inc Pa accumulated 162,940 shares. Victory Cap Mgmt owns 4,139 shares for 0% of their portfolio. 208,900 are held by Columbia Wanger Asset Management Limited Liability Com.

Synovus Financial Corp. operates as the bank holding firm for Synovus Bank that provides various financial services and products. The company has market cap of $6.03 billion. It offers integrated financial services, including commercial and retail banking, financial management, insurance, and mortgage services. It has a 23.36 P/E ratio. The companyÂ’s commercial banking services comprise cash management, asset management, capital market, and institutional trust services, as well as commercial, financial, and real estate loans.

The stock increased 0.90% or $0.45 during the last trading session, reaching $50.7. About 563,050 shares traded. Synovus Financial Corp. (NYSE:SNV) has risen 33.10% since March 6, 2017 and is uptrending. It has outperformed by 16.40% the S&P500.